A Clinical Study in Healthy Adults Who Sometimes Take Drugs for Pleasure to Investigate the Safety and Tolerability of GRT0151Y and to Find Out Which Single Dose of the Compound is Maximally Tolerated

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 20, 2006

Primary Completion Date

March 2, 2006

Study Completion Date

March 2, 2006

Conditions

PainAcute PainChronic Pain

Interventions

DRUG

GRT0151Y dose escalation

Single doses of 150, 200, 250, 300, 350 and 400 mg (3, 4, 5, 6, 7 or 8 capsules of 50 mg)

DRUG

Matching placebo

Matching placebo capsules (3, 4, 5, 6, 7 or 8 capsules)

Trial Locations (1)

Ventana Clinical Research Corporation, Toronto